Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open-Label Study of Zopapogene Imadenovec Retreatment and Vector Shedding Evaluation in Adult Patients With Recurrent Respiratory Papillomatosis

NCT06538480 is registered in ClinicalTrials.gov with Precigen, Inc as lead sponsor.

NCT NCT06538480
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06538480 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open-Label Study of Zopapogene Imadenovec Retreatment and Vector Shedding Evaluation in Adult Patients With Recurrent Respiratory Papillomatosis
Lead sponsor
Precigen, Inc
Phase
Phase 4
Overall status
Recruiting
Start date
July 11, 2024
Completion date
December 2, 2028
Enrollment
30 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

papillomaviridae, papillomavirus infection, recurrent respiratory papillomatosis